| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |